Drawing for MEDIDATA

USPTO serial 86091748

MEDIDATA

Reviewed by CopyMark Law Group

Reg. 4550995Status 800Registered
Filing date
Status date
Registration date
Jun 17, 2014
Examiner
MCPHERSON RAYBURN, SHAVELL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with MEDIDATA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A LaVine

Jordan A LaVine FLASTER/GREENBERG P.C.Suite 100, 100 Front StreetConshohocken, PA 19428United States

Goods and services

ClassDescriptionStatusFirst use
009Computer software for managing and sharing data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; downloadable software in the nature of a mobile application for use in managing data and information in the field of medical clinical trials and research; downloadable software in the nature of a mobile application for use in medical clinical trials, research monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchACTIVE—
041Online journals, namely, blogs featuring news, information and commentary in the field of medical clinical trials and research; providing a website featuring blogs and non-downloadable publications in the nature of blogs in the field of medical clinical trials and research; providing educational training in the field of computer software for use in managing data and information in the field of medical clinical trials and researchACTIVE—
042Software as a service (saas) solutions featuring software for managing and sharing data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; providing temporary use of online non-downloadable computer software for managing and sharing data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2024NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 14, 2024RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 14, 202489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 14, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 29, 2024E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 17, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Feb 28, 2020NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 28, 2020C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 28, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 3, 2020E815TEAS SECTION 8 & 15 RECEIVED—
Jun 17, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 17, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 1, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 1, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 12, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 20, 2014ALIEASSIGNED TO LIE—
Jan 31, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Jan 31, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 31, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 31, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 29, 2014DOCKASSIGNED TO EXAMINER—
Jan 7, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 23, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 22, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance